Close Menu

Appistry

The funding will be used to support Appistry's operations and engineering efforts, including the continued development of its GenomePilot DNA data-analysis software.

The partners have integrated WashU's VarScan with Appistry's GenomePilot, which provides preconfigured workflows for clinical NGS.

The new GenomePilot software application provides preconfigured analysis tools and pipelines for clinical research laboratories to analyze NGS data.

Appistry has hired Cornelius Boerkoel as its chief medical officer.

NEW YORK (GenomeWeb) – Through the newly launched Appistry Pipeline Challenge, bioinformatics firm Appistry is seeking to support the development and execution of a single next-generation sequencing analysis pipeline that addresses a need in the clinical research or precision medicine market.

MedPage Today and CollabRx have released CancerRx, an application that runs on Apple's operating system, that’s designed to help oncologists and pathologists navigate the complex landscape of oncology therapeutic options.

NEW YORK (GenomeWeb) – Appistry said today that it has signed a deal to include Personal Genome Diagnostics' CancerSelect panel in the recently released Appistry CloudDx genomics testing service.

NEW YORK (GenomeWeb) – Bina Technologies said today that it has signed a distribution agreement with Appistry that will allow the former to include runtime licenses for the latter's Genome Analysis Toolkit (GATK) and Cancer Genome Analysis (CGA) suite.

Appistry has soft-launched an early version of a new cloud-based genomic test ordering service that will target clinicians in community or regional hospitals who are interested in incorporating genomic testing into their practices but who may not have the domain knowledge necessa

Rather than develop separate solutions for parts of the market that fall outside their usual domains, Appistry and N-of-One have signed an agreement that lets them sell each other's content, technology, and services thus providing a complete solution for clients in the oncology m

Pages

US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.

The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.

Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.

In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.